Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000950170-25-091759
Filing Date
2025-06-30
Accepted
2025-06-30 17:49:25
Documents
1
Period of Report
2021-12-29

Document Format Files

Seq Description Document Type Size
1 4/A ownership.html 4/A  
1 4/A ownership.xml 4/A 3633
  Complete submission text file 0000950170-25-091759.txt   5146
Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1305 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address
Valantine Hannah (Reporting) CIK: 0001855608 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38959 | Film No.: 251093508